Location History:
- Lanarkshire, GB (2013 - 2014)
- Newhouse, GB (2010 - 2015)
Company Filing History:
1 out of 2,405 
1 out of 101 
1 out of 55 Years Active: 2010-2015
Title: The Innovative Contributions of Craig Jamieson
Introduction
Craig Jamieson is a notable inventor based in Newhouse, GB, recognized for his significant contributions to pharmaceutical chemistry. With a total of 5 patents, his work focuses on developing novel compounds that address various medical conditions.
Latest Patents
Among his latest patents, Jamieson has developed amino-heteroaryl derivatives as HCN blockers. This invention relates to amino-heteroaryl derivatives having a specific general formula or a pharmaceutically acceptable salt thereof. These compounds are designed for use in pharmaceutical compositions aimed at treating pain, including neuropathic and inflammatory pain. Another significant patent involves indane derivatives, which are defined by a specific formula. This invention also includes pharmaceutical compositions comprising these indane derivatives, which are intended for therapeutic use in treating psychiatric diseases such as schizophrenia, depression, and Alzheimer's disease.
Career Highlights
Throughout his career, Craig Jamieson has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and N.V. Organon. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Jamieson has collaborated with several professionals in his field, including John Kinnaird Ferguson MacLean and Elizabeth Margaret Moir. These collaborations have likely enhanced his research and development efforts.
Conclusion
Craig Jamieson's innovative work in pharmaceutical chemistry has led to the development of important compounds that have the potential to improve treatment options for various medical conditions. His contributions continue to impact the field positively.